NSC |
Compound |
Enrichment |
Correlation |
NSC 690290 |
15-oxozoapatlin |
0.00189155427362374 |
0.62950047 |
NSC 711741 |
Di-(1,3-dibromo-4-oxo-5,6-dihydro-4H-cyclopenta[c]thien-6-yl) amine |
0.00189155427362374 |
0.60998293 |
NSC 720340 |
Null |
0.00189155427362374 |
0.26162145 |
NSC 722779 |
dabequine |
0.00189155427362374 |
0.02358045 |
NSC 726718 |
3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid |
0.00189155427362374 |
0.46982807 |
NSC 727985 |
NSC 708781 incorporated in micelles, 0.55% (w/w) of drug |
0.00189155427362374 |
0.47250804 |
NSC 730460 |
16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate |
0.00189155427362374 |
0.40066443 |
NSC 745957 |
2-Benzylthio-4-chloro-N-[imino(3,4,5-trimethylpyrazol-1-yl)methyl]-5-methylbenzenesulfonamide |
0.00189155427362374 |
0.40034755 |
NSC 86371 |
Quinolinium, 2-[2-(8-hydroxy-5-methyl-7-quinolyl)vinyl]-1,6-dimethyl- iodide |
0.00189155427362374 |
0.49844952 |
NSC 372146 |
1,3,5-Triazine, 2-(1-methylethenyl)-2,4-diphenoxy- |
0.0019895000709106 |
0.53660097 |